This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Sep;206(3):628-629.

doi: 10.1097/JU.0000000000001797.01. Epub 2021 Jun 11.

Editorial Comment

David VanderWeele¹, Maha Hussain¹

Affiliations

Affiliation

¹ Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

PMID: 34115534
DOI: 10.1097/JU.0000000000001797.01

Editorial

Editorial Comment

David VanderWeele et al. J Urol. 2021 Sep.

. 2021 Sep;206(3):628-629.

doi: 10.1097/JU.0000000000001797.01. Epub 2021 Jun 11.

Authors

David VanderWeele¹, Maha Hussain¹

Affiliation

¹ Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

PMID: 34115534
DOI: 10.1097/JU.0000000000001797.01

No abstract available

PubMed Disclaimer

Comment on

Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies.
Marshall CH, Chen Y, Kuo C, Cullen J, Jiang J, Rosner I, Markowski M, McLeod DG, Trock BJ, Eisenberger MA. Marshall CH, et al. J Urol. 2021 Sep;206(3):623-629. doi: 10.1097/JU.0000000000001797. Epub 2021 May 18. J Urol. 2021. PMID: 34003011 Free PMC article.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources